about
Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience.Salvage treatment experience in advanced synovial sarcoma: a multicenter retrospective analysis of the Anatolian society of medical oncology.Cetuximab concomitant with second-line radiation therapy in patients with locally advanced recurrent squamous cell head and neck cancer.Management of brain metastases from non-small cell lung cancer.Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma.Pathologic and clinical characteristics of elderly patients with breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology).Clear cell adenocarcinoma of the uterine cervix: a case report and review of the literature.Multicenter experience of adult medulloblastoma: A study of Anatolian Society of Medical Oncology (ASMO).Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab.KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma.Biological Subtypes and Distant Relapse Pattern in Breast Cancer Patients After Curative Surgery (Study of Anatolian Society of Medical Oncology).Adult Urological Soft Tissue Sarcomas: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO).Sequential therapy and prognostic factors in metastatic renal cell carcinoma: single centre experience.Factors predicting recurrence in patients with grade III glial tumors: impact of adjuvant temozolomide on recurrence.Prognostic factors and adjuvant treatments for surgically treated cancers of the biliary tract: a multicentre study of the Anatolian Society of Medical Oncology (ASMO).Trastuzumab-based Retreatment after Lapatinib in Heavily Pretreated HER2 Positive Metastatic Breast Cancer: an Anatolian Society of Medical Oncology Study.Synchronous testicular liposarcoma and prostate adenocarcinoma: a case report.Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancerClinical significance of lymph node ratio in locally advanced breast cancer molecular subtypes.Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients.Prognostic factors for recurrence-free survival in patients with HER2-positive early-stage breast cancer treated with adjuvant trastuzumab.Functional and morphological effects of systemic bevacizumab on cancer patients' eyes.Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer.Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology.Clinicopathological features in bilateral breast cancer.Coexistence Hodgkin's lymphoma and colonic adenocarcinoma: a case report.Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology.Long term experience in high grade glial tumors with temozolomide.Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology.Assessment of right ventricular functions during cancer chemotherapy.Large cell neuroendocrine carcinoma: retrospective analysis of 24 cases from four oncology centers in Turkey.Treatment and prognostic factors in primary peritoneal carcinoma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO).Radiotherapy concurrent with weekly gemcitabine after transurethral tumor resection in muscle ınvasive bladder cancer.Prognostic importance of markers for inflammation, angiogenesis and apoptosis in high grade glial tumors during temozolomide and radiotherapy.Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers.Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancer.Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.Intracystic papillary carcinoma of the breast: one of the youngest patient in the literature.
P50
Q34656707-03B705AA-BD90-49DD-BB99-BFEB6DD1C372Q34657067-7F3A5BB2-D291-41D4-91C1-A6E10F31D72EQ34999913-D908694D-B8E9-4A45-86DB-08E0F4067C42Q35541331-EBC6FE5E-97AF-4A13-9765-BF65F1218990Q36029954-27D1F5A9-FC16-4772-924D-D83435B57A75Q37499050-D425C5AB-D4C2-4C04-91DA-5712091EA544Q38106588-1D1F62CE-FBF6-45C8-BB42-2247CFCA2090Q39702083-2894FAFE-A9D8-4374-83E5-7BAD92468473Q40956681-DD40B231-A7B5-4378-A42C-1D1AF8085952Q41207702-08EA606D-7ACD-434F-B84A-3623CA83EAD3Q41212534-0A459F57-C8C8-4924-B5F8-EA59464FA991Q41645086-475D626F-66B5-40B1-A797-AE3B81106E34Q41654578-E6E9DEA7-6407-4771-B6FB-3D06207472FEQ41654586-C341037D-DFC3-4D36-8B84-1B977675FB7EQ41675754-F7F40253-87E3-440D-9DFD-6BB030659B40Q41730114-3B4325A8-18DA-4AA3-9852-9DB8D23541AEQ41900890-89911251-8EF9-4176-AD78-D1D1B9E6A0D0Q42059647-5BD0B0E4-A0A7-4800-9A48-B0A4EE204C59Q42447964-F1F2BFF2-E279-4669-92D4-4A2DA0D8F44AQ43466291-1D0C5D31-01B1-49A2-9D1D-BA061E106090Q43901945-3EC55A53-62B3-48A8-9506-80FE621CAC4DQ44424486-16CF3B59-2110-4C3B-835A-A4372DCF48E6Q44664869-AB4E72AF-A233-4813-85C5-38711A7EF8C1Q45969231-F78E3432-ECD9-456D-8371-8BEAA2775AD7Q46007100-19BB27FC-21CE-41D3-A52E-9B3FE04A66C4Q46127045-4D9DF159-B762-4A4C-8903-9597C6DED451Q47813874-40A80E49-E446-4931-88FA-CBFBE6D25D28Q47832806-72A32229-0E84-462E-996C-020DBB634232Q47840383-9B749197-52A7-497E-A2F5-7DCE20F87799Q48458644-BC533813-2775-4BA8-A2B4-131888043155Q48831498-59B09163-F92F-4E44-8C5A-AB7885C6D243Q48924646-2435F70C-2D91-4F3B-815D-28F64C6E18A8Q50050578-53D83C80-11D7-45A9-A335-904E0315A482Q51135774-85FE1FB4-E778-43D1-8162-2638F45A06CBQ53173979-BC9C6CEF-B719-4A78-B825-BEBE07092D79Q53265090-C7D7976A-1C04-454E-B8BF-DC270BBC561EQ53424338-391FA6BE-D5BE-4397-AD6E-2F905DC310A3Q53746774-D3740D2D-B878-41B0-AD7B-43F9E7365315Q54386326-CEC951EC-2B66-4CA8-8C34-7F98D1E57166Q54726631-FFC41649-E116-4823-AB28-1B91D0AC2DC5
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-4833-6721
@en
name
Umut Demirci
@ast
Umut Demirci
@en
Umut Demirci
@es
Umut Demirci
@nl
type
label
Umut Demirci
@ast
Umut Demirci
@en
Umut Demirci
@es
Umut Demirci
@nl
prefLabel
Umut Demirci
@ast
Umut Demirci
@en
Umut Demirci
@es
Umut Demirci
@nl
P106
P31
P496
0000-0002-4833-6721